心誠鎂行動醫電股份有限公司 Approved
最後更新時間 2025/06/03 , 08:31 AM
最後更新時間 2025/06/03 , 08:31 AM
負責人
Zheng,Jie-Sheng
統一編號
24754176
成立日期
2014/10/06
資本額
NT$500,000,000
實收資本額
NT$326,807,620
股票代號
6934
電話
02-27326596
地址
10F, No. 319, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City, 106, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zheng,Jie-Sheng Chairman 9.61%
Cai,Wen-Yu Director 11.80%
YOU YANG MANAGEMENT CONSULTANT CO., LTD. Director 1.00%
Mahendra Shah Director 7.07% VIVO PANDA FUND, L.P.
Wu,Yong-Yi Director 0.14%
Zhong,Wei-Lian Director 0.00% AN RUI MANAGEMENT CONSULTANT LTD.
Fang,Shi-Hao Independent Director 0.00%
Zhang,Shang-Yuan Independent Director 0.00%
Zhou,Zhao-Long Independent Director 0.00%
Chen,Yi-Zhen Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Pharmaceutical and Medical Goods(457113)
  • 公司歷程
  • Change Capital to 500,000,000
    2021/02/26
  • Change Capital to 200,000,000
    2020/01/14
  • Change Capital to 80,000,000
    2019/04/15
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 18,849 9,235 6,478
    Operating cost 22,599 35,383 37,246
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) -3,750 -26,148 -30,768
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net -3,750 -26,148 -30,768
    Operating expenses 66,161 117,613 115,235
    Other gain (loss), net - - -
    Operating profit (loss) -69,911 -143,761 -146,003
    Non-operating income and expenses 1,597 -22,635 1,978
    Net profit (loss) before tax -68,314 -166,396 -144,025
    Income tax expense (benefits) -235 -470 -235
    Net profit (loss) of ongoing business for the current period -68,079 -165,926 -143,790
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -68,079 -165,926 -143,790
    Other comprehensive profit (loss), net 318 -173 -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -67,761 -166,099 -143,790
    Net profit (loss) attributable to owners of parent company -68,079 -165,926 -
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company -67,761 -166,099 -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) -2 -6 -6
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -61,896 -111,613 -
    Net cash inflows (outflows) from investing activities 61,835 -195,153 -
    Net cash inflow (outflow) from financing activities -6,403 250,048 -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 328 -165 -
    Increase (decrease) in cash and cash equivalents in the current period -6,136 -56,883 -
    Beginning balance of cash and cash equivalents 66,614 123,497 -
    Ending balance of cash and cash equivalents 60,478 66,614 -
    項目 2024 2023 2022
    Current asset 185,378 254,538 132,027
    Non-current asset 66,780 71,546 74,596
    Total asset 252,158 326,084 206,623
    Current liability 32,406 40,583 20,252
    Non-current liability 4,561 8,490 5,401
    Total liability 36,967 49,073 25,653
    share capital 300,337 300,107 244,107
    Equity - secruity token - - -
    capital reserve 442,582 436,871 230,731
    retained earning -527,873 -459,794 -293,868
    Other equity 145 -173 -
    Treasury stock - - -
    Total equity attributable to owners of parent company 215,191 277,011 -
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 215,191 277,011 180,970
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 7 9 7
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 特霧活
  • 圖形
  • AdheResp
  • Pulmogine
  • deepro
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2016
  • Others
    2018
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。